Cargando…

AMLS advanced medical life support: an assessment-based approach

Detalles Bibliográficos
Autor principal:	Jones and Bartlett
Lenguaje:	eng
Publicado:	Jones and Bartlett 2015
Acceso en línea:	http://cds.cern.ch/record/2159681

Ejemplares similares

Editorial: The latest advances in transplantation for AML
por: Chiusolo, Patrizia, et al.
Publicado: (2023)

Advanced Paediatric Life Support—The Practical Approach
por: Chambers, Timothy L
Publicado: (1993)

A Crowdsourcing Approach to Developing and Assessing Prediction Algorithms for AML Prognosis
por: Noren, David P., et al.
Publicado: (2016)

An assessment blueprint for the Advanced Medical Life Support two-day prehospital emergency medical services training program in the United States
por: Becker, Les R., et al.
Publicado: (2015)

Cost-efficiency assessment of Advanced Life Support (ALS) courses based on the comparison of advanced simulators with conventional manikins
por: Iglesias-Vázquez, José Antonio, et al.
Publicado: (2007)

Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges
por: Ling, Yuan, et al.
Publicado: (2017)

AML with Myelodysplasia-Related Changes: Development, Challenges, and Treatment Advances
por: Koenig, Kristin L., et al.
Publicado: (2020)

Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML
por: Bryant, Ashley Leak, et al.
Publicado: (2022)

Performing newborn life support in advance of neonatal advanced life support course—back to basics?
por: Hundscheid, Tim, et al.
Publicado: (2021)

P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED?
por: Huber, Sandra, et al.
Publicado: (2023)

Factors correlated with the advanced life support simulation performance of senior medical students
por: Park, KH, et al.
Publicado: (2010)

Advanced trauma life support course for medical students. A new era?
por: Vassiliu, Panteleimon, et al.
Publicado: (2022)

Advances in therapeutic options for newly diagnosed, high-risk AML patients
por: Doucette, Kimberley, et al.
Publicado: (2021)

CDK6 Inhibition: A Novel Approach in AML Management
por: Uras, Iris Z., et al.
Publicado: (2020)

Integrated multiomic approach for identification of novel immunotherapeutic targets in AML
por: Köhnke, Thomas, et al.
Publicado: (2022)

Advanced medical life support procedures in vitally compromised children by a helicopter emergency medical service
por: Gerritse, Bastiaan M, et al.
Publicado: (2010)

Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC
por: Huber, Sandra, et al.
Publicado: (2023)

Anesthesia advanced circulatory life support
por: Moitra, Vivek K., et al.
Publicado: (2012)

Major incident medical management and support: the practical approach at the scene
por: Mackway-Jones, Kevin
Publicado: (2012)

RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade
por: Ruzicka, Michael, et al.
Publicado: (2019)

AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets
por: Gardini, Alessandro, et al.
Publicado: (2008)

Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis
por: Masetti, Riccardo, et al.
Publicado: (2023)

Impact of FLT3-ITD location on cytarabine sensitivity in AML: a network-based approach
por: Pugliese, Giusj Monia, et al.
Publicado: (2023)

The role of the proteasome in AML
por: Csizmar, C M, et al.
Publicado: (2016)

Maintenance Therapy in AML
por: Reville, Patrick K., et al.
Publicado: (2021)

Students’ satisfaction to hybrid problem-based learning format for basic life support/advanced cardiac life support teaching
por: Chilkoti, Geetanjali, et al.
Publicado: (2016)

A case of high‐risk AML in a patient with advanced systemic mastocytosis
por: Fazio, Manlio, et al.
Publicado: (2023)

Far from Health: The Bone Marrow Microenvironment in AML, A Leukemia Supportive Shelter
por: Sendker, Stephanie, et al.
Publicado: (2021)

CALCRL Gene is a Suitable Prognostic Factor in AML/ETO(+) AML Patients
por: Wang, Rongrong, et al.
Publicado: (2022)

Teaching basic life support for medical students: Assessment of learning and knowledge retention
por: Silva, Nara Lúcia de Carvalho, et al.
Publicado: (2023)

MicroRNA–mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients
por: Bhise, Neha S., et al.
Publicado: (2016)

The Impact of Advanced Cardiac Life Support Simulation Training on Medical Student Self-reported Outcomes
por: Bowers, Kaitlin M, et al.
Publicado: (2020)

Advanced trauma life support course for physicians
Publicado: (1989)

ACLS (advanced cardiac life support) review /
Publicado: (2006)

P445: A SYSTEMS-BASED APPROACH TO UNVEIL DRUG RESISTANCE IN FLT3-ITD AML
por: Sacco, Francesca, et al.
Publicado: (2023)

Recent Advances in the Development of Anti-FLT3 CAR T-Cell Therapies for Treatment of AML
por: Pedersen, Maya Graham, et al.
Publicado: (2022)

Viewing AML through a New Lens: Technological Advances in the Study of Epigenetic Regulation
por: Godfrey, Laura C., et al.
Publicado: (2022)

Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML
por: Strachan, Debbie C., et al.
Publicado: (2022)

Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy
por: Versluis, Jurjen, et al.
Publicado: (2022)

Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications
por: Fodil, Sofiane, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_foc78bivv206uesdqq480klo8c